Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

healthcare funding

- PMLiVE

UK Government commit £50m to motor neurone disease research

The pledged funding is being placed into the hands of researchers ‘as quickly as possible’

- PMLiVE

Genomics England receives government funding for cutting-edge genomics research

£105m will be used to accelerate the diagnosis of rare genetic diseases in newborns

- PMLiVE

UK Government launches new taskforce to help NHS tackle COVID-19 backlogs

Experts will focus on how the NHS can utilise existing capacity in the independent sector

- PMLiVE

UK Government announces £113m to tackle ‘biggest’ public health challenges

A taskforce model, similar to the one that delivered COVID-19 vaccines, will be used

- PMLiVE

Alzheimer’s Research UK welcomes government’s recommitment to dementia mission

One million people are predicted to be living with dementia by 2025, increasing to 1.6 million by 2040

- PMLiVE

National trial to rapidly find treatments for severe flu this winter launched in UK

REMAP-CAP will test multiple treatments at the same time in thousands of people

Can Cinderella save us?

UK government launches consultation on silent AMR pandemic

The consultation will call upon the latest data from experts on antimicrobial resistance

- PMLiVE

UK Government announces £800m boost to support innovation and improve patient safety

The funding will be distributed by the National Institute for Health and Care Research

- PMLiVE

UK Government announces £50m research boost to tackle health inequalities

The investment will be given to 13 local authorities across the UK, from Aberdeen to Plymouth

- PMLiVE

NHS leaders urge government to take action on energy costs or risk ‘public health emergency’

There are concerns that widespread fuel poverty will increase the already high number of annual deaths associated with cold homes – estimated at around 10,000 a year

- PMLiVE

Sanofi and NIHR enrol first patient in immunisation study for RSV in infants

RSV is the leading global cause of infant hospitalisation and affects 90% of children under the age of two

- PMLiVE

UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns

The House of Lords Science and Technology Committee pointed to a lack of sustained focus, implementation and delivery in realising its 2030 ambitions

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links